| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/13/2006 | US7060250 Chelate compounds |
| 06/13/2006 | US7060248 Chelate compounds; diagnosis of disease; detection of conjestive heart failurel |
| 06/13/2006 | US7060247 Metal complexed with chelating group attached to gastrin releasing peptide receptor agonist which includes a bombesin agonist binding moiety; for use as therapeutic or diagnostic radiopharmaceutical |
| 06/08/2006 | WO2006037988A3 Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals |
| 06/08/2006 | WO2005087275A3 Metal radiolabeled pet imaging agents |
| 06/08/2006 | US20060122668 Method and apparatus for EMR treatment |
| 06/08/2006 | US20060120965 Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives |
| 06/08/2006 | US20060120960 Multivalent complexes, their production and method of use |
| 06/08/2006 | US20060120959 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 06/08/2006 | US20060120958 Solid-phase fluorination of uracil and cytosine |
| 06/08/2006 | US20060120957 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 06/08/2006 | US20060120956 Imaging agents comprising barbituric acid derivatives |
| 06/08/2006 | DE102004057225A1 Verfahren und Vorrichtung zur Isolierung eines chemisch und radiochemisch gereinigten 68Ga-Radionuklids und zum Markieren eines Markierungsvorläufers mit dem 68Ga-Radionuklid Method and apparatus for isolating a chemically and radiochemically purified 68 Ga radionuclide and for marking a labeling precursor with the radionuclide 68Ga |
| 06/07/2006 | EP1666072A1 Method of establishing the optimal radiation dose for a radiopharmaceutical treatment of disease |
| 06/07/2006 | EP1666045A1 Sphingomyelin containing preparation for the enhancement of tumor therapy and for the treatment of rheumatoid arthritis |
| 06/07/2006 | EP1664272A2 Targeting endothelium for tissue-specific delivery of agents |
| 06/07/2006 | EP1663868A2 Process for preparing radiolabelled compounds |
| 06/07/2006 | EP1663320A1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 06/07/2006 | EP1663319A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 06/07/2006 | EP1663318A1 A radioisotope-chitosan complex for treatment of prostate cancer |
| 06/07/2006 | EP1476467B1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 06/07/2006 | EP1140965B1 Antibacterial protonated oligonucleotides |
| 06/07/2006 | CN2785598Y Structural improvement of imbeded particle |
| 06/06/2006 | US7056275 Radiotherapy |
| 06/01/2006 | WO2006057323A1 Composition for amyloid-associated disease diagnosis |
| 06/01/2006 | WO2005117976A3 Method of increasing radiation sensitivity by inhibition of beta one integrin |
| 06/01/2006 | WO2005094327A3 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling |
| 06/01/2006 | WO2005084716A3 Phospholipid analogs for diagnosis and treatment of cancer |
| 06/01/2006 | WO2005046438A3 Internal clamp for surgical procedures |
| 06/01/2006 | WO2005014479A3 Process for preparing radiolabeled compounds |
| 06/01/2006 | US20060115428 Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
| 06/01/2006 | US20060115427 Diagnosis and assessment of skeletal related disease using calcium 41 |
| 06/01/2006 | US20060115426 Methods of detecting breast cancer, brain cancer, and pancreatic cancer |
| 06/01/2006 | US20060115425 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 06/01/2006 | US20060115424 Combination therapy of oxaliplatin and radioactively doped particles treating cancer |
| 05/31/2006 | EP1661995A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/31/2006 | EP1660519A2 Fluorinated carbohydrate conjugates |
| 05/31/2006 | EP1660137A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1272223B1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 05/31/2006 | EP1207910B1 Composition comprising diagnostic agents in silica-coated containers |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | CN1781021A N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 05/31/2006 | CN1780679A Method of obtaining gallium-68 and use thereof and device for carrying out said method |
| 05/30/2006 | US7052673 Anticancer, antitumor agents; mixture of metal, drug, peptide and carriers |
| 05/30/2006 | US7052672 Stabilized radiopharmaceutical compositions |
| 05/26/2006 | WO2006054904A2 Contrast agents to target extracellular matrix |
| 05/26/2006 | WO2006054466A1 Novel radioactive technetium/bisphosphinoamine complex and radioactive imaging diagnostic agent containing the complex |
| 05/26/2006 | WO2006054296A2 Methods of detecting prostate cancer |
| 05/26/2006 | WO2006053785A1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality |
| 05/26/2006 | WO2006044660A3 Functionalized solid lipid nanoparticles and methods of making and using same |
| 05/26/2006 | WO2006003123A3 Radionuclides for medical use |
| 05/26/2006 | WO2005028021A3 Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy |
| 05/26/2006 | CA2588381A1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality |
| 05/25/2006 | WO2006026184A9 Blood brain barrier permeation peptides |
| 05/25/2006 | US20060111552 Metal binding precursors for the synthesis of peptide-metal conjugates |
| 05/25/2006 | US20060111273 Water soluble paclitaxel derivatives |
| 05/25/2006 | US20060110773 Marker for inflammatory conditions |
| 05/25/2006 | US20060110324 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/25/2006 | US20060110323 Method of imaging cell death in vivo |
| 05/25/2006 | US20060110322 Assay for vitamin B12 absorption and method of making labeled vitamin B12 |
| 05/24/2006 | EP1658282A1 Novel chelating agents and chelates and their use |
| 05/24/2006 | EP1658099A1 Compounds and kits for preparing imaging agents and methods of imaging |
| 05/24/2006 | EP1658049A2 Ferromagnetic particles and methods |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | CN2782094Y Degradable particle source for internal local radiotherapy |
| 05/24/2006 | CN1777446A A medicament for the two-step perioperative therapy of solid tumours |
| 05/23/2006 | US7050694 Continuously variable attenuation of an optical signal using an optical isolator |
| 05/23/2006 | US7049398 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 05/23/2006 | US7049289 Labelled glutamine and lysine analogues |
| 05/23/2006 | US7048953 Comprises periodic inhalation of concentrated vapors from Eucalyptus oil |
| 05/23/2006 | US7048907 Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2351207C Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 05/18/2006 | WO2006052691A2 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 05/18/2006 | WO2006052292A1 Method for continuous visualization of a blood clot or plaque in a body lumen |
| 05/18/2006 | WO2006051341A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | WO2005099776A3 Steroid sparing agents and methods of using same |
| 05/18/2006 | WO2005097672A3 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 05/18/2006 | US20060106273 Directional-ionizing energy emitting implant |
| 05/18/2006 | US20060106219 making a fluoro radioactive material [18F]Fluorohaloalkanes radiotracer through halogenation, or solid phase synthesis; use in positron emission tomography (PET) studies |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 05/18/2006 | US20060105396 Novel epithelial tissue imaging agent |
| 05/18/2006 | US20060104900 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | US20060104898 Targeting ligands comprising an amino acid sequence for guided targeting of irradiated glioma, a melanoma, and a lung carcinoma |
| 05/18/2006 | US20060104897 Method for diagnosing and treating nis-expressing carcinomas and metastases |
| 05/18/2006 | CA2588073A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | CA2586661A1 Antibodies against tenascin-c |
| 05/18/2006 | CA2586220A1 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 05/17/2006 | EP1656954A1 Therapeutic human albumin solutions with low prekallicrein activator (PKA) activity and process for obtaining them |
| 05/17/2006 | EP1656560A2 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 05/17/2006 | EP1656160A1 Radioimmunoconjugates for targeted alpha therapy |
| 05/17/2006 | EP1519917A4 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters |
| 05/17/2006 | EP1012563A4 Breath test for detection of drug metabolism |
| 05/17/2006 | EP1007101B1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/17/2006 | CN1774267A Amyloid-binding, metal-chelating agents |